药物洗脱球囊：东山再起的后起之秀？ - Suppr

Suppr

超能文献

Drug-eluting balloon: the comeback kid?

作者信息

Waksman Ron, Pakala Rajbabu

机构信息

Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, Washington, DC 20010, USA.

出版信息

Circ Cardiovasc Interv. 2009 Aug;2(4):352-8. doi: 10.1161/CIRCINTERVENTIONS.109.873703.

DOI:10.1161/CIRCINTERVENTIONS.109.873703

PMID:20031739

Abstract

摘要

相似文献

Drug-eluting balloon: the comeback kid?

Circ Cardiovasc Interv. 2009 Aug;2(4):352-8. doi: 10.1161/CIRCINTERVENTIONS.109.873703.

Paclitaxel-eluting balloon: from bench to bed.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):643-52. doi: 10.1002/ccd.21895.

Clinical presentation of patients with late target lesion revascularization.

Catheter Cardiovasc Interv. 2008 Nov 1;72(5):749. doi: 10.1002/ccd.21663.

Stent fracture-unusual cause of DES restenosis.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):993-4. doi: 10.1002/ccd.21241.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.

Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):599. doi: 10.1002/ccd.21568.

Preparing for the worst.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):634-5. doi: 10.1002/ccd.22484.

Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):944-9. doi: 10.1002/ccd.21731.

Stent implantation as effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and follow-up.

Catheter Cardiovasc Interv. 2008 May 1;71(6):842. doi: 10.1002/ccd.21578.

Ann Med. 2006;38(3):173-87. doi: 10.1080/07853890600643404.

引用本文的文献

Coronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions.

Medicina (Kaunas). 2025 Aug 15;61(8):1470. doi: 10.3390/medicina61081470.

Drug-coated balloons for the treatment of in-stent restenosis: an updated systematic review and meta-analysis of randomized controlled trials.

Ann Med Surg (Lond). 2024 Dec 12;87(8):5165-5172. doi: 10.1097/MS9.0000000000003496. eCollection 2025 Aug.

Towards the Integration of an Anti-Contractile Compound Within Drug-Coated Balloon Therapy.

Cardiovasc Eng Technol. 2025 Jul 25. doi: 10.1007/s13239-025-00798-7.

Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease.

Catheter Cardiovasc Interv. 2025 Sep;106(3):1843-1853. doi: 10.1002/ccd.70005. Epub 2025 Jul 15.

Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?

Front Med Technol. 2025 Apr 30;7:1546417. doi: 10.3389/fmedt.2025.1546417. eCollection 2025.

Drug coated balloon angioplasty for de novo coronary lesions in large vessels: a systematic review and meta-analysis.

Sci Rep. 2025 Feb 10;15(1):4921. doi: 10.1038/s41598-025-85734-4.

A Comparison of 2 Paclitaxel-Coated Balloon Systems in Treatment of De Novo Coronary Artery Lesions.

J Soc Cardiovasc Angiogr Interv. 2024 Feb 15;3(5):101295. doi: 10.1016/j.jscai.2024.101295. eCollection 2024 May.

Endovascular Drug Delivery.

Life (Basel). 2024 Mar 28;14(4):451. doi: 10.3390/life14040451.

Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.

ACS Appl Bio Mater. 2024 May 20;7(5):3041-3049. doi: 10.1021/acsabm.4c00080. Epub 2024 Apr 25.

Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data.

Cardiovasc Drugs Ther. 2025 Jun;39(3):677-686. doi: 10.1007/s10557-024-07548-2. Epub 2024 Jan 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Drug-eluting balloon: the comeback kid?

作者信息

Waksman Ron, Pakala Rajbabu

机构信息

Division of Cardiology, Department of Internal Medicine, Washington Hospital Center, Washington, DC 20010, USA.

出版信息

Circ Cardiovasc Interv. 2009 Aug;2(4):352-8. doi: 10.1161/CIRCINTERVENTIONS.109.873703.

DOI:10.1161/CIRCINTERVENTIONS.109.873703

PMID:20031739

Abstract

摘要

相似文献

Drug-eluting balloon: the comeback kid?

Circ Cardiovasc Interv. 2009 Aug;2(4):352-8. doi: 10.1161/CIRCINTERVENTIONS.109.873703.

Paclitaxel-eluting balloon: from bench to bed.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):643-52. doi: 10.1002/ccd.21895.

Clinical presentation of patients with late target lesion revascularization.

Catheter Cardiovasc Interv. 2008 Nov 1;72(5):749. doi: 10.1002/ccd.21663.

Stent fracture-unusual cause of DES restenosis.

Catheter Cardiovasc Interv. 2007 Jun 1;69(7):993-4. doi: 10.1002/ccd.21241.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550.

Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.

Catheter Cardiovasc Interv. 2008 Apr 1;71(5):599. doi: 10.1002/ccd.21568.

Preparing for the worst.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):634-5. doi: 10.1002/ccd.22484.

Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):944-9. doi: 10.1002/ccd.21731.

Stent implantation as effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and follow-up.

Catheter Cardiovasc Interv. 2008 May 1;71(6):842. doi: 10.1002/ccd.21578.

Ann Med. 2006;38(3):173-87. doi: 10.1080/07853890600643404.

引用本文的文献

Coronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions.

Medicina (Kaunas). 2025 Aug 15;61(8):1470. doi: 10.3390/medicina61081470.

Drug-coated balloons for the treatment of in-stent restenosis: an updated systematic review and meta-analysis of randomized controlled trials.

Ann Med Surg (Lond). 2024 Dec 12;87(8):5165-5172. doi: 10.1097/MS9.0000000000003496. eCollection 2025 Aug.

Towards the Integration of an Anti-Contractile Compound Within Drug-Coated Balloon Therapy.

Cardiovasc Eng Technol. 2025 Jul 25. doi: 10.1007/s13239-025-00798-7.

Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease.

Catheter Cardiovasc Interv. 2025 Sep;106(3):1843-1853. doi: 10.1002/ccd.70005. Epub 2025 Jul 15.

Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?

Front Med Technol. 2025 Apr 30;7:1546417. doi: 10.3389/fmedt.2025.1546417. eCollection 2025.

Drug coated balloon angioplasty for de novo coronary lesions in large vessels: a systematic review and meta-analysis.

Sci Rep. 2025 Feb 10;15(1):4921. doi: 10.1038/s41598-025-85734-4.

A Comparison of 2 Paclitaxel-Coated Balloon Systems in Treatment of De Novo Coronary Artery Lesions.

J Soc Cardiovasc Angiogr Interv. 2024 Feb 15;3(5):101295. doi: 10.1016/j.jscai.2024.101295. eCollection 2024 May.

Endovascular Drug Delivery.

Life (Basel). 2024 Mar 28;14(4):451. doi: 10.3390/life14040451.

Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.

ACS Appl Bio Mater. 2024 May 20;7(5):3041-3049. doi: 10.1021/acsabm.4c00080. Epub 2024 Apr 25.

Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data.

Cardiovasc Drugs Ther. 2025 Jun;39(3):677-686. doi: 10.1007/s10557-024-07548-2. Epub 2024 Jan 25.